At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Adaptive Biobehavioral Control (ABC) of Automated Insulin Delivery: A Randomized, Controlled Pilot Study
In Brief
A clinical study evaluating Web Simulation Tool (WST), Behavioral Adaptation Module (BAM), and 2 other interventions for Type 1 Diabetes Mellitus. Completed, enrolled 31 participants across 1 site.
Detailed Summary
The purpose of this pilot study is to test the safety and feasibility of using two or three research modules in conjunction with an automated insulin delivery device (AID).
Study Details
Timeline
Interventions
WST will allow users of the Control-IQ system replay treatment scenarios in computer simulation, thereby allowing user training with carbohydrate and insulin action.
BAM provides on-demand information to the participant primarily on glycemic risks.
ATM provides recommendations to the participant to periodically update insulin parameters.
The t:slim X2 insulin pump with Control-IQ technology, Tandem Diabetes Care will be the AID in this study.